| 24/06 | QUANTERIX CORP : Change in Directors or Principal Officers, Financial Statements and Exhib.. | AQ |
| 09/06 | Quanterix to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference | BU |
| 06/06 | QUANTERIX : Announces Appointment of Karen A. Flynn to Board of Directors - Form 8-K | PU |
| 06/06 | QUANTERIX CORP : Change in Directors or Principal Officers, Financial Statements and Exhib.. | AQ |
| 06/06 | Quanterix Announces Appointment of Karen A. Flynn to Board of Directors | BU |
| 19/05 | QUANTERIX CORP : Change in Directors or Principal Officers, Financial Statements and Exhib.. | AQ |
| 10/05 | QUANTERIX CORP Management's Discussion and Analysis of Financial Condition and Results.. | AQ |
| 10/05 | Quanterix Corporation Releases Operating Results for First Quarter 2022 | BU |
| 03/05 | Quanterix Corporation to Release First Quarter 2022 Financial Results on May 10, 2022 | BU |
| 28/04 | QUANTERIX CORP : Change in Directors or Principal Officers, Financial Statements and Exhib.. | AQ |
| 22/04 | Quanterix Granted Breakthrough Device Designation from U.S. FDA for NfL Test for Multip.. | BU |
| 04/04 | Quanterix' Simoa® Technology Powers Large, International Comprehensive Reference Range .. | BU |
| 29/03 | Quanterix Receives Funding from the Alzheimer's Drug Discovery Foundation to Accelerate.. | BU |
| 09/03 | Quanterix to Participate in Barclays Global Healthcare Conference | BU |
| 03/03 | Quanterix to Participate in The Cowen 42nd Annual Health Care Conference On March 9 | BU |
| 01/03 | QUANTERIX CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS.. | AQ |
| 01/03 | QUANTERIX : Releases Operating Results for Fourth Quarter and Full Year 2021 - Form 8-K | PU |
| 01/03 | QUANTERIX CORP : Results of Operations and Financial Condition, Change in Directors or Pri.. | AQ |
| 01/03 | Quanterix Announces Executive Leadership Succession Plan | BU |
| 01/03 | Quanterix Corporation Releases Operating Results for Fourth Quarter and Full Year 2021 | BU |
| 01/03 | Quanterix Announces New Agreements with Lilly to Advance Alzheimer's Disease Diagnosis .. | BU |
| 28/02 | Quanterix Corporation Garners Five Best Places to Work Awards from Comparably | BU |
| 23/02 | Quanterix Corporation to Release Fourth Quarter and Full Year 2021 Financial Results on.. | BU |
| 09/02 | Quanterix to Participate in the SVB Leerink Global Healthcare Conference | BU |
| 08/02 | UK Dementia Research Institute Biomarker Factory Powers Alzheimer's Disease Breakthroug.. | BU |
| 31/01 | QUANTERIX CORP : Entry into a Material Definitive Agreement, Financial Statements and Exhi.. | AQ |
| 26/01 | Quanterix' Simoa® Technology Powers Latest Breakthrough in Epstein-Barr Virus and Multi.. | BU |
| 13/01 | QUANTERIX : Provides Operational and Preliminary Financial Highlights - Form 8-K | PU |
| 13/01 | Quanterix Provides Operational and Preliminary Financial Highlights | BU |
| 06/01 | Quanterix to Present at 40th Annual J.P. Morgan Healthcare Conference | BU |
| 2021 | Quanterix Recognized as a Fastest-Growing Company in North America on the 2021 Deloitte.. | BU |
| 2021 | Quanterix' Simoa® Technology Powers Advances in Alzheimer's Disease Research Presented .. | BU |
| 2021 | QUANTERIX CORP : Change in Directors or Principal Officers, Financial Statements and Exhib.. | AQ |
| 2021 | Quanterix to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics and Digi.. | BU |
| 2021 | Quanterix Co-Inventor of Simoa® David Walt Receives Kabiller Prize in Nanoscience and N.. | BU |
| 2021 | Quanterix Corporation Releases Operating Results for Third Quarter of 2021 - Form 8-K | PU |
| 2021 | QUANTERIX CORP Management's Discussion and Analysis of Financial Condition and Results.. | AQ |
| 2021 | Quanterix Corporation Releases Operating Results for Third Quarter of 2021 | BU |
| 2021 | Quanterix Corporation to Release Third Quarter 2021 Financial Results on Nov. 4, 2021 | BU |
| 2021 | QUANTERIX : Granted Breakthrough Device Designation from U.S. FDA for Blood-Based pTau-181.. | BU |
| 2021 | QUANTERIX : Hosts Webinar with Leading Pathologist from Emory Medical Laboratories | BU |
| 2021 | QUANTERIX : Receives Label Expansion on Emergency Use Authorization for COVID Antigen Test | BU |
| 2021 | QUANTERIX TO HOST WEBINAR WITH LEADI : “COVID-19 Testing in a Residential University.. | BU |
| 2021 | QUANTERIX CORP : Change in Directors or Principal Officers, Financial Statements and Exhib.. | AQ |
| 2021 | CASSAVA SCIENCES : Releases Statement Regarding Plasma p-tau Analysis from a Previously Di.. | AQ |
| 2021 | QUANTERIX : Releases Statement | BU |
| 2021 | QUANTERIX : to Participate in the Canaccord Genuity 41st Annual Growth Conference | BU |
| 2021 | QUANTERIX : Simoa® Technology Powers Breakthrough Alzheimer's Disease Research Presented b.. | BU |
| 2021 | QUANTERIX : Management's Discussion and Analysis of Financial Condition and Results of Ope.. | AQ |
| 2021 | QUANTERIX CORPORATION : Releases Operating Results for Second Quarter of 2021 | BU |
| 2021 | QUANTERIX CORPORATION : to Release Second Quarter 2021 Financial Results on Aug. 5, 2021 | BU |
| 2021 | QUANTERIX : Appoints Michael Doyle as Chief Financial Officer Doyle brings strong financia.. | PU |
| 2021 | QUANTERIX CORP : Change in Directors or Principal Officers, Financial Statements and Exhib.. | AQ |
| 2021 | QUANTERIX : Appoints Michael Doyle as Chief Financial Officer | BU |
| 2021 | QUANTERIX CORP : Submission of Matters to a Vote of Security Holders, Financial Statements.. | AQ |
| 2021 | QUANTERIX : rsquo; Simoa Technology Powers Largest and Most Diverse Global Investigation o.. | PU |
| 2021 | QUANTERIX : rsquo; Simoa Technology Powers Largest and Most Diverse Global Investigation o.. | BU |
| 2021 | QUANTERIX : Chairman and CEO Kevin Hrusovsky to Present at the Goldman Sachs 42 Annual Glo.. | PU |
| 2021 | QUANTERIX : Chairman and CEO Kevin Hrusovsky to Present at the Goldman Sachs 42nd Annual G.. | BU |
| 2021 | QUANTERIX : Toloue brings deep expertise and industry acumen to lead the Company's strateg.. | PU |
| 2021 | QUANTERIX CORP : Change in Directors or Principal Officers, Financial Statements and Exhib.. | AQ |
| 2021 | QUANTERIX : Appoints Masoud Toloue as President of Quanterix and Diagnostics | BU |
| 2021 | QUANTERIX : Q1 GAAP revenue including grant revenue $27.2M; Q1 non-GAAP revenue $24.9M, an.. | PU |
| 2021 | QUANTERIX : Management's Discussion and Analysis of Financial Condition and Results of Ope.. | AQ |
| 2021 | QUANTERIX : Q1 2021 Earnings Call | PU |
| 2021 | QUANTERIX CORPORATION : Releases Operating Results for First Quarter 2021 | BU |
| 2021 | QUANTERIX CORPORATION : to Release First Quarter 2021 Financial Results on May 5, 2021 | BU |
| 2021 | QUANTERIX : Pharmaceutical veteran adds deep expertise in commercial and corporate strateg.. | PU |
| 2021 | QUANTERIX CORP : Change in Directors or Principal Officers, Financial Statements and Exhib.. | AQ |
| 2021 | QUANTERIX : Appoints Laurie Olson to Board of Directors | BU |
| 2021 | QUANTERIX WEBINAR : Recent Advancements in Neurodegenerative Biomarkers: Progress Towards .. | BU |
| 2021 | QUANTERIX CORP : Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
| 2021 | QUANTERIX : Announces Appointment of Interim Chief Financial Officer | BU |
| 2021 | QUANTERIX CORP : Change in Directors or Principal Officers (form 8-K) | AQ |
| 2021 | QUANTERIX CORP : Change in Directors or Principal Officers (form 8-K) | AQ |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (België)
Rapport
